JSJose Daniel Sanchez

Jose Daniel Sanchez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jose Daniel Sanchez has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Augmentation or erosion? Artificial intelligence and the transformation of clinical reasoning: a critical narrative review

    by José Daniel Sánchez, José Daniel

    Background: Artificial intelligence (AI) systems are used to support diagnosis, but a model’s accuracy does not establish that clinicians reason more accurately when they use it. This review appraises how AI decision support and large language models affect physicians’ diagnostic performance and the risks of relying on them. Methods: This critical narrative review follows the Scale for the Assessment of Narrative Review Articles. Scopus, PubMed/MEDLINE, SciELO and LILACS were searched in July and August 2026 in English, Spanish and Portuguese. Eligible studies, published from 2015 onward, compared AI-assisted with unassisted clinicians, measured reliance on AI or unassisted performance after exposure to it, or externally validated deployed models. A single author selected sources purposively. Nine primary studies were appraised with an adapted Critical Appraisal Skills Programme framework. Results: In randomized trials of perceptual tasks, AI support improved detection. In the MASAI mammography screening trial, cancer detection rose from 5.0 to 6.4 per 1,000 women, reading workload fell by 44%, and the interval-cancer rate was non-inferior. In colonoscopy, computer-aided detection raised the adenoma detection rate from 40.4% to 54.8%. In the only randomized trial of open-ended diagnostic reasoning, access to GPT-4 did not improve physicians’ scores (76% vs. 74%; P = .60 ), although the model alone scored 92%. Evidence of harm came from smaller or non-randomized studies: reader accuracy fell sharply when AI suggestions were incorrect or the AI missed a cancer; physicians trained in AI literacy were still misled by erroneous model advice; unassisted adenoma detection fell from 28.4% to 22.4% after routine AI use in one pre–post study; and a deployed sepsis model discriminated poorly on external validation (area under the curve 0.63). No eligible study from Latin America was identified. Conclusions: In the studies reviewed, AI assistance improved clinician performance in bounded detection tasks but not in open-ended diagnostic reasoning, where evidence is limited to one vignette-based trial. The evidence that reliance on AI can impair performance comes from single or design-limited studies and does not establish how large or lasting such effects are. Benefit therefore cannot be inferred from model accuracy alone; assisted and unassisted clinician performance should be measured directly.

  • Open Access

    Promise, Mimicry, and Surveillance: Responsibly Integrating Artificial Intelligence With Socratic Inquiry in Medical Education

    by José Daniel Sánchez

    Large language models are increasingly proposed as a way to deliver Socratic dialogue at scale in medical education, offering personalized, always-available, and lower-stakes inquiry that human educators cannot logistically provide. In this viewpoint, I argue that this promise is plausible but unproven and that 2 failure modes deserve more attention than they currently receive. The first is the mimicry trap: a system that fluently generates Socratic-sounding questions can appear to cultivate reasoning while functioning as interactive content delivery. I position this as an educational instance of the ELIZA effect and of the proxy-outcome problem; separating conversational mimicry from genuine metacognitive gain remains a central unresolved evaluation problem. The second is what I term the Panopticon Paradox: the data collection that makes AI tutoring effective may erode the psychological safety that Socratic inquiry requires, pushing learners toward performative rather than authentic engagement, in a manner analogous to gaming behaviors documented in intelligent tutoring systems. I present this second construct as a testable causal model with specified mediators, moderators, and falsifiable predictions rather than as an established finding. Because the evidence base is dominated by proof-of-concept tools, cross-sectional surveys, and short-term evaluations, I argue that AI is complementary rather than a replacement technology, and I propose a 3-pillar framework (governance, curriculum, and faculty development) tied explicitly to the 2 failure modes. I distinguish 4 modalities of delegation and argue that ethical deliberation, emotionally complex communication, and ambiguous clinical judgment cannot presently be recommended for autonomous or primary AI delivery.


  • Open Access

    Mathematical Modeling in Infectious Disease Epidemiology: A Systematic Scoping Review of Theoretical Foundations, Structural Typologies, and Applications for Global Public Health (Preprint)

    by Jose Sánchez

    BACKGROUND Mathematical models have become the intellectual infrastructure of modern infectious disease epidemiology. However, the literature on this topic is highly fragmented across different model families, specific pathogens, and methodological niches, lacking a comprehensive and integrative synthesis. OBJECTIVE This systematic scoping review aims to synthesize the theoretical foundations, structural typology, and public health applications of mathematical models in infectious disease epidemiology, while identifying critical methodological gaps to guide future research and practice. METHODS We conducted a systematic scoping review following the Arksey and O'Malley framework, updated by Levac et al. and the Joanna Briggs Institute guidelines, reported according to the PRISMA extension for Scoping Reviews (PRISMA-ScR). We searched six electronic databases (PubMed/MEDLINE, Embase, Web of Science, Scopus, MathSciNet, and Google Scholar) for literature published between January 1991 and December 2025. From 4,217 initially identified records, 228 were assessed in full text, and 50 studies were included in the final synthesis. RESULTS The review identified and systematically compared six structural model families: deterministic compartmental, stochastic, network-based, agent-based, statistical/hybrid, and fractional-order. Key epidemiological parameters synthesized included the basic reproduction number (R₀), the effective reproduction number R(t), the case fatality ratio (CFR), and the latent and incubation periods. Documented R₀ estimates ranged from 1.4-1.6 for pandemic influenza H1N1 (2009) to 12-18 for measles in unvaccinated populations. Applications spanned tuberculosis, HIV/AIDS, SARS, MERS-CoV, pandemic influenza, dengue fever, and COVID-19. While 96% of studies transparently described their model structure, only 28% provided code or data for reproducibility. To address a critical gap in behavioral modeling, we propose a parsimonious bio-behavioral dynamic transmission rate (β(t) = max(0, β₀ + αt - θI)) that incorporates adherence fatigue and prevalence-elastic risk awareness. The review identified three critical methodological gaps: validation during early outbreak phases, integration of human behavior, and systematic comparisons between model families. CONCLUSIONS Mathematical models are indispensable tools for infectious disease epidemiology, yet their maximum utility depends on robust validation, methodological transparency, and high-quality data. This review provides a comprehensive typological comparison and synthesis of documented parameters while articulating an actionable research agenda prioritizing standardized validation platforms, behavioral integration, and multidisciplinary collaboration for future global health emergencies.

  • Open Access

    Political stability, health system resilience, and macroeconomic shocks as factors associated with malaria control outcomes: a comparative analysis of Ecuador and Venezuela (2000–2023)

    by Jose Daniel Sanchez Redroban, Maria Cristina Mideros Mora, Melissa Jaramillo Pérez

    The post-2000 period in South America presents a striking divergence in malaria epidemiology: Ecuador achieved a >99% reduction in malaria incidence

  • Open Access

    AI Socrates: Promise, Mimicry, and Surveillance in Medical Education – A Viewpoint on Responsibly Integrating Artificial Intelligence with Socratic Inquiry for Clinical Reasoning (Preprint)

    by Jose Sánchez

    BACKGROUND Artificial intelligence (AI), particularly large language models (LLMs), is increasingly proposed to deliver Socratic dialogue at scale in medical education. However, the gap between conversational fluency and genuine pedagogical effect remains underexamined. OBJECTIVE This viewpoint argues that while AI holds promise for scalable Socratic tutoring, two critical problems—the mimicry trap and the Panopticon Paradox—require urgent attention. It also proposes a responsible integration framework and defines limits on AI delegation. METHODS This is a conceptual viewpoint and argument synthesis. The author critically reviews current evidence (including systematic reviews, randomized controlled trials, quasi-experimental studies, and proof-of-concept systems), identifies structural failure modes, and proposes a three-pillar framework for integration. RESULTS Current evidence shows AI improves engagement, self-efficacy, and satisfaction but lacks longitudinal or comparative trials demonstrating durable clinical reasoning outcomes. The mimicry trap describes how fluent Socratic-sounding questions may not produce genuine metacognitive gains. The Panopticon Paradox describes how surveillance required for personalization may erode psychological safety, pushing learners toward performative engagement. The paper proposes governance, curriculum, and faculty development as three interdependent pillars, and defines limits: AI should not be trusted for ethical deliberation, emotionally complex communication, or ambiguous clinical judgment. CONCLUSIONS AI is best understood as a complementary technology, not a replacement. Responsible integration requires engineering around specific failure modes, empirical testing of the Panopticon Paradox, and clear limits on delegation. The research agenda includes longitudinal trials, equity audits, and governance experiments.

  • Kabisa: A Support for Teaching Decision Making in Medicine, Comparative Study

    by José Daniel Sánchez Redroban, María Fernanda Navas, Federico Ferrero

  • Open Access

    The pharmaceutical industry’s multifaceted role in neglected tropical disease control: from market failure to global health innovation

    by Jose Daniel Sanchez

    Neglected tropical diseases (NTDs) represent a profound market failure wherein pharmaceutical innovation systematically underserves populations with the greatest need. Despite affecting over 1.7 billion people globally, NTDs receive less than 2% of pharmaceutical research and development (R&D) investment. This review synthesises evidence on the pharmaceutical industry's evolving role in NTD control, examining both traditional commercial models and innovative partnerships that have reshaped the global health landscape, with particular attention to implementation mechanisms and concrete operational pathways. We conducted a comprehensive analysis of WHO reports, G-FINDER data, peer-reviewed literature, and industry commitments spanning 2000-2024, focusing on drug development pipelines, mass drug administration programmes, and financing mechanisms. Product Development Partnerships (PDPs) have delivered 183 approved products since 1999, though the majority represent reformulations or repurposed compounds rather than novel chemical entities (NCEs). Mass drug administration programmes have distributed over 17 billion treatments from pharmaceutical donations valued at approximately $30 billion (at wholesale prices), preventing millions of disability-adjusted life years. However, persistent innovation gaps remain: only 4 NCEs (0.5% of all new therapeutics 2000-2011) specifically targeted NTDs. Diagnostic development continues to lag due to commercial barriers and fragmented regulatory pathways. The pharmaceutical industry's contribution to NTD control has evolved from minimal engagement to strategic partnerships blending philanthropic drug donation, nonprofit-led R&D, and market-based incentives. While mechanisms including Priority Review Vouchers and Advance Market Commitments show potential, their effectiveness remains debated in the literature, particularly regarding access provisions and additionality. Future progress requires sustained push funding for PDPs, multi-year donor commitments, expansion of WHO prequalification for diagnostics, and strengthened South-South technology-transfer partnerships with concrete implementation frameworks.


  • Open Access

    Reemergerence and Geospatial Shift of Human Brucellosis in Ecuador (1992-2025): A Multi-Source Epidemiological Analysis of Surveillance, Hospitalization, and Provincial Distribution Data

    by José Daniel Sánchez Redrobán, Carlos Carrasco

    Background: Brucellosis, a neglected zoonosis caused primarily by Brucella abortus, persists as an endemic challenge in Ecuador. However, the absence of a unified, quality-audited national dataset has constrained epidemiological modeling and evidence-based policy design.Objective: To construct and analyze a consolidated epidemiological database of human brucellosis in Ecuador spanning 1992-2025, integrating three independent surveillance sources, and to characterize temporal trends, regional heterogeneity, hospitalization burden, and the impact of the COVID-19 pandemic on notification.Methods: We conducted a retrospective, multi-source data integration study. Case data were extracted from the SIVE-ALERTA national surveillance subsystem (Ministry of Public Health), the Hospital Discharges Registry (INEC), and the GIDEON international database. Critical discrepancies between sources were resolved through documentary audit of official epidemiological bulletins. A 34-year national time series (1992-2025) and a spatiotemporal panel dataset (2020-2025) were assembled. Descriptive epidemiological analyses, incidence rate calculations, and provincial clustering assessments were performed.Results: A total of 339 confirmed human cases were identified nationally between 1992 and 2025. Four distinct epidemiological eras were delineated: controlled endemicity (1992-2007; 1-24 cases/year), epidemiological silence following vaccination campaigns (2008-2011; 0 cases), progressive reemergence (2012-2019; peak of 45 cases in 2019 at 0.26/100,000), and post-pandemic resurgence (2021-2025). A critical data discrepancy for 2020 was resolved: 45 cases attributed to 2020 by GIDEON were confirmed as belonging to 2019, while only 2 notifications occurred in 2020 due to COVID-19-related surveillance collapse. Projected 2025 incidence (47 cases, 0.25/100,000) approaches the highest levels in a quarter-century. A striking geospatial shift was identified: the primary epicenter migrated from the Andean highlands (Imbabura, 8 cases in 2024) to the coastal province of Guayas (22 cases in the first 16 epidemiological weeks of 2025 alone). Analysis of 79 hospital discharges (2020-2024) revealed near-parity in sex distribution (55.7% male, 44.3% female), zero in-hospital mortality, and a major temporal cluster in October 2024 (8 simultaneous admissions).Conclusions: Ecuador is experiencing an accelerating reemergence of human brucellosis with an unprecedented coastal displacement of the disease focus. The documented surveillance gaps, compounded by COVID-19 disruption, underscore the urgent need for strengthened One Health approaches, mandatory bovine vaccination compliance, and integrated molecular-serological diagnostics.

  • Open Access

    Sodium, potassium, and blood pressure regulation in Latin American populations: a critical narrative review of multifactorial determinants

    by Ariel Torres, Jose Daniel Sanchez Redroban, Giselle Trujillo, Andres Perez

    Background: Salt-sensitive hypertension represents a critical yet inadequately understood public health challenge in Latin America, where sodium intake substantially exceeds international recommendations while potassium consumption remains deficient. The complex interplay between dietary electrolytes, genetic susceptibility, and socioecological determinants necessitates comprehensive analytical frameworks that transcend traditional biomedical models. Methods: This critical narrative review synthesizes evidence from approximately 154 peer-reviewed publications identified through structured searches in PubMed/MEDLINE, LILACS, SciELO, Scopus, Web of Science, Google Scholar, and SciSpace, covering the period 2015–2025. Sources were selected to represent the breadth of available evidence on sodium and potassium intake patterns, blood pressure regulation, genetic determinants of salt sensitivity, and socioecological contexts in Latin American adult populations. A multi-level analytical framework incorporating physiological mechanisms, epidemiological evidence, genetic determinants, and socioecological contexts was applied for narrative synthesis. Studies published before 2015, including landmark trials and foundational epidemiological work, are cited as background context. Results: Latin American populations demonstrate consistently elevated sodium excretion (8.4–8.9 g/day salt equivalent) and inadequate potassium intake (1.4–1.5 g/day), yielding unfavorable sodium-to-potassium ratios strongly associated with hypertension prevalence and cardiovascular risk. The landmark Peruvian salt substitution trial demonstrated that community-wide replacement with potassium-enriched alternatives reduced systolic blood pressure by 1.29 mmHg, diastolic by 0.76 mmHg, and incident hypertension by 51% over 30 months. Salt sensitivity exhibits marked heterogeneity, modulated by genetic variants affecting renal sodium handling, obesity, age, and structural determinants governing food access. The sodium-to-potassium ratio emerges as a more robust predictor than either mineral independently. Conclusions: Understanding hypertension in Latin America requires integrating biological mechanisms with cultural practices, socioeconomic inequalities, and food system transformations. Evidence-based interventions including salt substitution, comprehensive sodium reduction strategies, and potassium enhancement must address implementation barriers including cost, industry engagement, surveillance gaps, and equity dimensions. Future research priorities include standardized exposure assessment protocols, scaled intervention trials, food-source attribution analyses, and socioecological implementation science to translate evidence into sustainable, equitable population health improvements.

  • Open Access

    Drug-Resistant Tuberculosis in Prisons of Latin America and the Caribbean: A Critical Reflection on Structural Challenges and Gaps

    by Ariel Torres, Gisselle Trujillo, José Daniel Sánchez

    Drug-resistant tuberculosis (DR-TB) represents a major public health threat, particularly in the prisons of Latin America and the Caribbean, where rates are up to 40 times higher than those observed in the general population. These facilities act as community amplifiers due to overcrowding, poor ventilation, diagnostic delays, and treatment discontinuity. This study offers a critical reflection on the magnitude, determinants, and implications of DR-TB in regional penitentiary contexts. A reflective analytical review was conducted in PubMed, Scopus, Web of Science, SciELO, and LILACS, complemented by WHO and PAHO reports, prioritising studies from 2019 to 2024. The findings reveal MDR-TB and pre-extensively drug-resistant (pre-XDR) outbreaks in Peru, Paraguay, and the Dominican Republic, as well as community transmission linked to prisons in Brazil and Colombia. Persistent gaps remain in systematic screening, drug susceptibility testing coverage, and post-release follow-up. Scientific production continues to be uneven and predominantly biomedical, with limited consideration of social and human rights determinants. DR-TB in prisons reflects the structural deficiencies of health and justice systems; its control requires intersectoral policies, genomic surveillance, and strategies that ensure early diagnosis, treatment continuity, and dignified detention conditions.